• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰老心脏:分子与临床挑战

The Aging Heart: A Molecular and Clinical Challenge.

机构信息

IRCCS Fondazione Don Carlo Gnocchi, 20132 Milan, Italy.

School of Medicine, Università Vita-Salute San Raffaele, 20132 Milan, Italy.

出版信息

Int J Mol Sci. 2022 Dec 16;23(24):16033. doi: 10.3390/ijms232416033.

DOI:10.3390/ijms232416033
PMID:36555671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9783309/
Abstract

Aging is associated with an increasing burden of morbidity, especially for cardiovascular diseases (CVDs). General cardiovascular risk factors, ischemic heart diseases, heart failure, arrhythmias, and cardiomyopathies present a significant prevalence in older people, and are characterized by peculiar clinical manifestations that have distinct features compared with the same conditions in a younger population. Remarkably, the aging heart phenotype in both healthy individuals and patients with CVD reflects modifications at the cellular level. An improvement in the knowledge of the physiological and pathological molecular mechanisms underlying cardiac aging could improve clinical management of older patients and offer new therapeutic targets.

摘要

衰老是发病率负担增加的一个因素,特别是心血管疾病(CVDs)。一般心血管危险因素、缺血性心脏病、心力衰竭、心律失常和心肌病在老年人中具有较高的患病率,其临床表现与年轻人群中的相同疾病有明显不同。值得注意的是,健康个体和 CVD 患者的衰老心脏表型反映了细胞水平的改变。改善心脏衰老的生理和病理分子机制的认识可以改善老年患者的临床管理,并提供新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f0d/9783309/7f1a6364c757/ijms-23-16033-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f0d/9783309/499bb4b14c4e/ijms-23-16033-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f0d/9783309/3c5ab152b2a5/ijms-23-16033-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f0d/9783309/6a3681daeff4/ijms-23-16033-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f0d/9783309/1e21b6f38558/ijms-23-16033-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f0d/9783309/cb6aece73ca5/ijms-23-16033-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f0d/9783309/d81e3ea9e5c5/ijms-23-16033-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f0d/9783309/7f1a6364c757/ijms-23-16033-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f0d/9783309/499bb4b14c4e/ijms-23-16033-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f0d/9783309/3c5ab152b2a5/ijms-23-16033-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f0d/9783309/6a3681daeff4/ijms-23-16033-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f0d/9783309/1e21b6f38558/ijms-23-16033-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f0d/9783309/cb6aece73ca5/ijms-23-16033-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f0d/9783309/d81e3ea9e5c5/ijms-23-16033-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f0d/9783309/7f1a6364c757/ijms-23-16033-g007.jpg

相似文献

1
The Aging Heart: A Molecular and Clinical Challenge.衰老心脏:分子与临床挑战
Int J Mol Sci. 2022 Dec 16;23(24):16033. doi: 10.3390/ijms232416033.
2
Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC).遗传性扩张型和肥厚型心肌病的靶向治疗:从分子机制到治疗靶点。心力衰竭协会(HFA)和欧洲心脏病学会(ESC)心肌功能工作组的立场文件。
Eur J Heart Fail. 2022 Mar;24(3):406-420. doi: 10.1002/ejhf.2414. Epub 2022 Jan 14.
3
The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease.促炎细胞因子在心血管疾病发病机制中的作用。
Int J Mol Sci. 2024 Jan 16;25(2):1082. doi: 10.3390/ijms25021082.
4
Association between hypertensive disorders of pregnancy and cardiovascular diseases within 24 months after delivery.妊娠高血压疾病与产后 24 个月内心血管疾病的关系。
Am J Obstet Gynecol. 2023 Jul;229(1):65.e1-65.e15. doi: 10.1016/j.ajog.2023.04.006. Epub 2023 Apr 7.
5
Cardiomyopathies in Women.女性心肌病。
Methodist Debakey Cardiovasc J. 2024 Mar 14;20(2):59-69. doi: 10.14797/mdcvj.1368. eCollection 2024.
6
The care of elderly patients with cardiovascular disease.老年心血管疾病患者的护理。
Ann Intern Med. 1988 Sep 1;109(5):425-8. doi: 10.7326/0003-4819-109-5-425.
7
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology.心肌病心力衰竭:欧洲心脏病学会心力衰竭协会立场文件。
Eur J Heart Fail. 2019 May;21(5):553-576. doi: 10.1002/ejhf.1461. Epub 2019 Apr 16.
8
Cardiovascular disease in the elderly.老年人的心血管疾病
Ciba Found Symp. 1988;134:106-28. doi: 10.1002/9780470513583.ch8.
9
Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies.扩张型心肌病、肥厚型心肌病、限制型心肌病和致心律失常性右室心肌病中的心源性猝死发生率、风险评估和预防。
Eur J Heart Fail. 2023 Dec;25(12):2144-2163. doi: 10.1002/ejhf.3076. Epub 2023 Nov 14.
10
Management of heart failure in elderly people.老年人心力衰竭的管理
Int J Clin Pract. 2008 Feb;62(2):270-80. doi: 10.1111/j.1742-1241.2007.01583.x. Epub 2007 Dec 7.

引用本文的文献

1
Fenofibrate Differently Affects the Heart's Morphology and Metabolism in Young and Old Rats.非诺贝特对年轻和老年大鼠心脏的形态和代谢有不同影响。
Int J Mol Sci. 2025 Aug 20;26(16):8038. doi: 10.3390/ijms26168038.
2
Nothobranchius furzeri: a vertebrate model for studying cardiac aging and cellular senescence.费氏假鳃鳉:一种用于研究心脏衰老和细胞衰老的脊椎动物模型。
NPJ Aging. 2025 Jul 11;11(1):63. doi: 10.1038/s41514-025-00253-w.
3
Impact of plant-derived antioxidants on heart aging: a mechanistic outlook.植物源抗氧化剂对心脏衰老的影响:机制展望

本文引用的文献

1
Geriatric Cardiology: Coming of Age.老年心脏病学:走向成熟。
JACC Adv. 2022 Aug;1(3). doi: 10.1016/j.jacadv.2022.100070. Epub 2022 Aug 26.
2
Myosins and MyomiR Network in Patients with Obstructive Hypertrophic Cardiomyopathy.梗阻性肥厚型心肌病患者中的肌球蛋白与肌微RNA网络
Biomedicines. 2022 Sep 3;10(9):2180. doi: 10.3390/biomedicines10092180.
3
Polypill Strategy in Secondary Cardiovascular Prevention.复方药治疗在二级心血管预防中的应用。
Front Pharmacol. 2025 Mar 21;16:1524584. doi: 10.3389/fphar.2025.1524584. eCollection 2025.
4
Klotho in age-related cardiovascular diseases: Insights into mitochondrial dysfunction and cell death.衰老相关心血管疾病中的klotho:对线粒体功能障碍和细胞死亡的见解
Int J Cardiol Heart Vasc. 2025 Mar 8;57:101629. doi: 10.1016/j.ijcha.2025.101629. eCollection 2025 Apr.
5
Exercise in Diabetic Cardiomyopathy: Its Protective Effects and Molecular Mechanism.糖尿病心肌病中的运动:其保护作用及分子机制
Int J Mol Sci. 2025 Feb 10;26(4):1465. doi: 10.3390/ijms26041465.
6
Immunometabolism in the Aging Heart.衰老心脏中的免疫代谢
J Am Heart Assoc. 2025 Jan 7;14(1):e039216. doi: 10.1161/JAHA.124.039216. Epub 2024 Dec 24.
7
Dietary Intake of Polyunsaturated Fatty Acids Is Associated with Blood Glucose and Diabetes in Community-Dwelling Older Adults.社区居住的老年人膳食中多不饱和脂肪酸的摄入量与血糖及糖尿病有关。
Nutrients. 2024 Nov 27;16(23):4087. doi: 10.3390/nu16234087.
8
The Impact of Vitamin E Supplementation on Oxidative Stress, Cognitive Functions, and Aging-Related Gene Expression in Aged Mice.维生素E补充剂对老年小鼠氧化应激、认知功能及衰老相关基因表达的影响
Food Sci Nutr. 2024 Oct 26;12(11):9834-9845. doi: 10.1002/fsn3.4548. eCollection 2024 Nov.
9
Real-world research on beta-blocker usage trends in China and safety exploration based on the FDA Adverse Event Reporting System (FAERS).中国β受体阻滞剂使用趋势的真实世界研究和基于 FDA 不良事件报告系统(FAERS)的安全性探索。
BMC Pharmacol Toxicol. 2024 Nov 14;25(1):86. doi: 10.1186/s40360-024-00815-w.
10
Biomembrane-Modified Biomimetic Nanodrug Delivery Systems: Frontier Platforms for Cardiovascular Disease Treatment.生物膜修饰仿生纳米药物递送系统:心血管疾病治疗的前沿平台。
Biomolecules. 2024 Aug 7;14(8):960. doi: 10.3390/biom14080960.
N Engl J Med. 2022 Sep 15;387(11):967-977. doi: 10.1056/NEJMoa2208275. Epub 2022 Aug 26.
4
Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions.在保留左心室射血分数的心力衰竭中的炎症途径:对未来干预的影响。
Cardiovasc Res. 2023 Feb 3;118(18):3536-3555. doi: 10.1093/cvr/cvac133.
5
Transthyretin cardiac amyloidosis.转甲状腺素蛋白心脏淀粉样变性。
Cardiovasc Res. 2023 Feb 3;118(18):3517-3535. doi: 10.1093/cvr/cvac119.
6
The WNT/β-catenin pathway regulates expression of the genes involved in cell cycle progression and mitochondrial oxidative phosphorylation in the postmitotic cardiac myocytes.WNT/β-连环蛋白信号通路调控有丝分裂后心肌细胞中参与细胞周期进程和线粒体氧化磷酸化的基因表达。
J Cardiovasc Aging. 2022;2(2). doi: 10.20517/jca.2021.35. Epub 2022 Jan 28.
7
Cardiovascular disease in the elderly: proceedings of the European Society of Cardiology-Cardiovascular Round Table.老年人心血管疾病:欧洲心脏病学会-心血管圆桌会议记录。
Eur J Prev Cardiol. 2022 Aug 5;29(10):1412-1424. doi: 10.1093/eurjpc/zwac033.
8
Telomere dysfunction in ageing and age-related diseases.端粒功能障碍与衰老和衰老相关疾病。
Nat Cell Biol. 2022 Feb;24(2):135-147. doi: 10.1038/s41556-022-00842-x. Epub 2022 Feb 14.
9
Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.《心脏病与卒中统计-2022 更新:美国心脏协会报告》。
Circulation. 2022 Feb 22;145(8):e153-e639. doi: 10.1161/CIR.0000000000001052. Epub 2022 Jan 26.
10
Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathy.应激激活的信号通路损害了人类肥厚型心肌病中的蛋白质质量控制途径。
Int J Cardiol. 2021 Dec 1;344:160-169. doi: 10.1016/j.ijcard.2021.09.009. Epub 2021 Sep 10.